Sunitinib V. Pazopanib in the First Line Setting Patients receiving sunitinib had better overall survival - 100098

Spotlight
Video

Sunitinib V. Pazopanib in the First Line Setting Patients receiving sunitinib had better overall survival

kidneycancer has 473 videos Subscribe Here

Loading........
Description: Aly-Khan Lalani, MD Dana Farber Cancer Institute, discusses Sunitinib V. Pazopanib in the First Line Setting Patients receiving sunitinib had better overall survival at Kidney Cancer Association 2017 in Miami.
Shared By : kidneycancer
Posted on : 02/22/18
Added : 7 months ago
Category : Kidney Cancer



Recommended

Nothing found.